nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Rivaroxaban—CYP3A4—breast cancer	0.00483	0.546	CrCbGaD
Linezolid—MAOB—nipple—breast cancer	0.00476	0.0866	CbGeAlD
Linezolid—MAOA—nipple—breast cancer	0.00407	0.0738	CbGeAlD
Linezolid—Rivaroxaban—ABCB1—breast cancer	0.00402	0.454	CrCbGaD
Linezolid—MAOB—embryo—breast cancer	0.00393	0.0714	CbGeAlD
Linezolid—MAOA—embryo—breast cancer	0.00335	0.0609	CbGeAlD
Linezolid—MAOB—endometrium—breast cancer	0.00288	0.0523	CbGeAlD
Linezolid—MAOB—uterus—breast cancer	0.00265	0.0482	CbGeAlD
Linezolid—MAOB—pituitary gland—breast cancer	0.0026	0.0473	CbGeAlD
Linezolid—MAOB—adipose tissue—breast cancer	0.00259	0.0471	CbGeAlD
Linezolid—MAOA—endometrium—breast cancer	0.00245	0.0446	CbGeAlD
Linezolid—MAOB—female reproductive system—breast cancer	0.00238	0.0433	CbGeAlD
Linezolid—MAOB—adrenal gland—breast cancer	0.00233	0.0422	CbGeAlD
Linezolid—MAOA—uterus—breast cancer	0.00226	0.0411	CbGeAlD
Linezolid—MAOA—pituitary gland—breast cancer	0.00222	0.0403	CbGeAlD
Linezolid—MAOA—adipose tissue—breast cancer	0.00221	0.0402	CbGeAlD
Linezolid—MAOB—female gonad—breast cancer	0.00217	0.0394	CbGeAlD
Linezolid—MAOA—female reproductive system—breast cancer	0.00203	0.0369	CbGeAlD
Linezolid—MAOB—endocrine gland—breast cancer	0.00202	0.0366	CbGeAlD
Linezolid—MAOA—adrenal gland—breast cancer	0.00198	0.036	CbGeAlD
Linezolid—MAOA—female gonad—breast cancer	0.00185	0.0336	CbGeAlD
Linezolid—MAOA—endocrine gland—breast cancer	0.00172	0.0313	CbGeAlD
Linezolid—MAOB—lymph node—breast cancer	0.00139	0.0253	CbGeAlD
Linezolid—MAOA—lymph node—breast cancer	0.00119	0.0216	CbGeAlD
Linezolid—MAOA—Biological oxidations—ALDH1A1—breast cancer	0.000845	0.00448	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	0.000843	0.00447	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—MTR—breast cancer	0.000832	0.00441	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—HPGDS—breast cancer	0.000816	0.00432	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTT1—breast cancer	0.000792	0.00419	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000789	0.00418	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	0.000758	0.00401	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—KCNH1—breast cancer	0.000757	0.00401	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA3—breast cancer	0.000753	0.00399	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP17A1—breast cancer	0.000749	0.00397	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	0.000745	0.00395	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—PTGS1—breast cancer	0.000742	0.00393	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2D6—breast cancer	0.000727	0.00385	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—NCOA2—breast cancer	0.000714	0.00378	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	0.000711	0.00376	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	0.0007	0.00371	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA4—breast cancer	0.000689	0.00365	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA2—breast cancer	0.000671	0.00356	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000664	0.00352	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—SULT1A1—breast cancer	0.000663	0.00351	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA1—breast cancer	0.000648	0.00343	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP3A4—breast cancer	0.000642	0.0034	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—NAT2—breast cancer	0.000641	0.00339	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP1B1—breast cancer	0.000631	0.00334	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—NCOA1—breast cancer	0.000602	0.00319	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000598	0.00317	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP19A1—breast cancer	0.000593	0.00314	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000565	0.00299	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	0.000565	0.00299	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—COMT—breast cancer	0.000551	0.00292	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTP1—breast cancer	0.000549	0.00291	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—MTR—breast cancer	0.000522	0.00277	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—HPGDS—breast cancer	0.000512	0.00271	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTM1—breast cancer	0.000504	0.00267	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTT1—breast cancer	0.000497	0.00263	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000494	0.00261	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP1A1—breast cancer	0.000478	0.00253	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP17A1—breast cancer	0.00047	0.00249	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—PTGS1—breast cancer	0.000465	0.00247	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2D6—breast cancer	0.000456	0.00242	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—NCOA2—breast cancer	0.000448	0.00237	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000443	0.00235	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—ACHE—breast cancer	0.00044	0.00233	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000414	0.0022	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP3A4—breast cancer	0.000403	0.00213	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP1B1—breast cancer	0.000396	0.0021	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—AR—breast cancer	0.000391	0.00207	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SYNJ2—breast cancer	0.000385	0.00204	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—BCHE—breast cancer	0.000384	0.00203	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—NCOA1—breast cancer	0.000378	0.002	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP19A1—breast cancer	0.000372	0.00197	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NDUFS3—breast cancer	0.000357	0.00189	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—COMT—breast cancer	0.000346	0.00183	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTP1—breast cancer	0.000344	0.00182	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HES1—breast cancer	0.000344	0.00182	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ACHE—breast cancer	0.000337	0.00179	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CHST9—breast cancer	0.000336	0.00178	CbGpPWpGaD
Linezolid—MAOB—Metabolism—COX11—breast cancer	0.000319	0.00169	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTM1—breast cancer	0.000316	0.00168	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—COMT—breast cancer	0.000307	0.00162	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP1A1—breast cancer	0.0003	0.00159	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—BCHE—breast cancer	0.000294	0.00156	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CDA—breast cancer	0.000291	0.00154	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SHMT1—breast cancer	0.000291	0.00154	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000288	0.00153	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLCO1B1—breast cancer	0.000281	0.00149	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC2A5—breast cancer	0.000281	0.00149	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APRT—breast cancer	0.000271	0.00144	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ANGPTL4—breast cancer	0.000255	0.00135	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ESRRA—breast cancer	0.000255	0.00135	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GPI—breast cancer	0.000241	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HADHB—breast cancer	0.000241	0.00128	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SYNJ2—breast cancer	0.000241	0.00128	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—COMT—breast cancer	0.000235	0.00124	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALDH7A1—breast cancer	0.00023	0.00122	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALDH1A1—breast cancer	0.00023	0.00122	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NDUFS3—breast cancer	0.000224	0.00119	CbGpPWpGaD
Linezolid—Asthenia—Irinotecan—breast cancer	0.000223	0.000299	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—breast cancer	0.000223	0.000298	CcSEcCtD
Linezolid—Cough—Capecitabine—breast cancer	0.000223	0.000298	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—breast cancer	0.000222	0.000297	CcSEcCtD
Linezolid—MAOB—Metabolism—UMPS—breast cancer	0.000221	0.00117	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PHGDH—breast cancer	0.000221	0.00117	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADSL—breast cancer	0.000221	0.00117	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NME1—breast cancer	0.000221	0.00117	CbGpPWpGaD
Linezolid—MAOB—Metabolism—FHL2—breast cancer	0.000221	0.00117	CbGpPWpGaD
Linezolid—Neutropenia—Doxorubicin—breast cancer	0.000221	0.000295	CcSEcCtD
Linezolid—Decreased appetite—Paclitaxel—breast cancer	0.00022	0.000295	CcSEcCtD
Linezolid—Hypertension—Capecitabine—breast cancer	0.00022	0.000295	CcSEcCtD
Linezolid—Dry mouth—Docetaxel—breast cancer	0.000219	0.000293	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000219	0.000293	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—breast cancer	0.000219	0.000293	CcSEcCtD
Linezolid—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000219	0.000293	CcSEcCtD
Linezolid—Fatigue—Paclitaxel—breast cancer	0.000219	0.000293	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—breast cancer	0.000218	0.000292	CcSEcCtD
Linezolid—Asthenia—Gemcitabine—breast cancer	0.000217	0.000291	CcSEcCtD
Linezolid—Pain—Paclitaxel—breast cancer	0.000217	0.00029	CcSEcCtD
Linezolid—Constipation—Paclitaxel—breast cancer	0.000217	0.00029	CcSEcCtD
Linezolid—MAOB—Metabolism—HPSE—breast cancer	0.000217	0.00115	CbGpPWpGaD
Linezolid—MAOB—Metabolism—BRIP1—breast cancer	0.000217	0.00115	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LDHB—breast cancer	0.000217	0.00115	CbGpPWpGaD
Linezolid—Pharyngitis—Methotrexate—breast cancer	0.000216	0.00029	CcSEcCtD
Linezolid—Anaphylactic shock—Docetaxel—breast cancer	0.000215	0.000288	CcSEcCtD
Linezolid—Pruritus—Gemcitabine—breast cancer	0.000214	0.000287	CcSEcCtD
Linezolid—Nausea—Thiotepa—breast cancer	0.000214	0.000286	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—breast cancer	0.000213	0.000285	CcSEcCtD
Linezolid—Diarrhoea—Mitoxantrone—breast cancer	0.000213	0.000285	CcSEcCtD
Linezolid—Diarrhoea—Irinotecan—breast cancer	0.000213	0.000285	CcSEcCtD
Linezolid—Dry mouth—Capecitabine—breast cancer	0.000212	0.000284	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—breast cancer	0.000212	0.000283	CcSEcCtD
Linezolid—MAOA—Metabolism—CHST9—breast cancer	0.000211	0.00112	CbGpPWpGaD
Linezolid—Pruritus—Fluorouracil—breast cancer	0.000211	0.000282	CcSEcCtD
Linezolid—Thrombocytopenia—Docetaxel—breast cancer	0.00021	0.000282	CcSEcCtD
Linezolid—Skin disorder—Docetaxel—breast cancer	0.000209	0.000279	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000209	0.000279	CcSEcCtD
Linezolid—Gastrointestinal pain—Paclitaxel—breast cancer	0.000207	0.000278	CcSEcCtD
Linezolid—Diarrhoea—Gemcitabine—breast cancer	0.000207	0.000277	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—breast cancer	0.000207	0.000277	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—breast cancer	0.000206	0.000276	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—breast cancer	0.000206	0.000276	CcSEcCtD
Linezolid—Dizziness—Irinotecan—breast cancer	0.000206	0.000275	CcSEcCtD
Linezolid—MAOB—Metabolism—ABCC1—breast cancer	0.000205	0.00109	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA3—breast cancer	0.000205	0.00109	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMMR—breast cancer	0.000205	0.00109	CbGpPWpGaD
Linezolid—Haemoglobin—Epirubicin—breast cancer	0.000205	0.000274	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—breast cancer	0.000205	0.000274	CcSEcCtD
Linezolid—Anorexia—Docetaxel—breast cancer	0.000205	0.000274	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—breast cancer	0.000204	0.000273	CcSEcCtD
Linezolid—Diarrhoea—Fluorouracil—breast cancer	0.000204	0.000273	CcSEcCtD
Linezolid—Thrombocytopenia—Capecitabine—breast cancer	0.000204	0.000273	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—breast cancer	0.000203	0.000272	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—breast cancer	0.000203	0.000272	CcSEcCtD
Linezolid—Pharyngitis—Epirubicin—breast cancer	0.000203	0.000271	CcSEcCtD
Linezolid—Skin disorder—Capecitabine—breast cancer	0.000202	0.000271	CcSEcCtD
Linezolid—Urticaria—Paclitaxel—breast cancer	0.000201	0.00027	CcSEcCtD
Linezolid—Hyperhidrosis—Capecitabine—breast cancer	0.000201	0.000269	CcSEcCtD
Linezolid—Body temperature increased—Paclitaxel—breast cancer	0.0002	0.000268	CcSEcCtD
Linezolid—Abdominal pain—Paclitaxel—breast cancer	0.0002	0.000268	CcSEcCtD
Linezolid—MAOA—Metabolism—COX11—breast cancer	0.0002	0.00106	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARGC1B—breast cancer	0.000199	0.00105	CbGpPWpGaD
Linezolid—Anorexia—Capecitabine—breast cancer	0.000198	0.000265	CcSEcCtD
Linezolid—Vomiting—Mitoxantrone—breast cancer	0.000198	0.000265	CcSEcCtD
Linezolid—Vomiting—Irinotecan—breast cancer	0.000198	0.000265	CcSEcCtD
Linezolid—Dizziness—Fluorouracil—breast cancer	0.000197	0.000264	CcSEcCtD
Linezolid—Rash—Irinotecan—breast cancer	0.000196	0.000262	CcSEcCtD
Linezolid—Rash—Mitoxantrone—breast cancer	0.000196	0.000262	CcSEcCtD
Linezolid—Dermatitis—Mitoxantrone—breast cancer	0.000196	0.000262	CcSEcCtD
Linezolid—Dermatitis—Irinotecan—breast cancer	0.000196	0.000262	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—BRAF—breast cancer	0.000196	0.00104	CbGpPWpGaD
Linezolid—Chills—Methotrexate—breast cancer	0.000196	0.000262	CcSEcCtD
Linezolid—Headache—Irinotecan—breast cancer	0.000195	0.000261	CcSEcCtD
Linezolid—Headache—Mitoxantrone—breast cancer	0.000195	0.000261	CcSEcCtD
Linezolid—Insomnia—Docetaxel—breast cancer	0.000194	0.00026	CcSEcCtD
Linezolid—Paraesthesia—Docetaxel—breast cancer	0.000193	0.000258	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—breast cancer	0.000193	0.000258	CcSEcCtD
Linezolid—Vomiting—Gemcitabine—breast cancer	0.000193	0.000258	CcSEcCtD
Linezolid—Dyspnoea—Docetaxel—breast cancer	0.000192	0.000256	CcSEcCtD
Linezolid—Somnolence—Docetaxel—breast cancer	0.000191	0.000256	CcSEcCtD
Linezolid—Rash—Gemcitabine—breast cancer	0.000191	0.000256	CcSEcCtD
Linezolid—Dermatitis—Gemcitabine—breast cancer	0.000191	0.000255	CcSEcCtD
Linezolid—Tinnitus—Epirubicin—breast cancer	0.00019	0.000255	CcSEcCtD
Linezolid—Erythema—Methotrexate—breast cancer	0.00019	0.000254	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—breast cancer	0.00019	0.000254	CcSEcCtD
Linezolid—Headache—Gemcitabine—breast cancer	0.00019	0.000254	CcSEcCtD
Linezolid—Vomiting—Fluorouracil—breast cancer	0.000189	0.000253	CcSEcCtD
Linezolid—Dyspepsia—Docetaxel—breast cancer	0.000189	0.000253	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—breast cancer	0.000189	0.000253	CcSEcCtD
Linezolid—Insomnia—Capecitabine—breast cancer	0.000188	0.000252	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—breast cancer	0.000188	0.000251	CcSEcCtD
Linezolid—Rash—Fluorouracil—breast cancer	0.000188	0.000251	CcSEcCtD
Linezolid—MAOB—Metabolism—CA9—breast cancer	0.000188	0.000995	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA4—breast cancer	0.000188	0.000995	CbGpPWpGaD
Linezolid—Dermatitis—Fluorouracil—breast cancer	0.000188	0.000251	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—breast cancer	0.000187	0.000251	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000187	0.000991	CbGpPWpGaD
Linezolid—Paraesthesia—Capecitabine—breast cancer	0.000187	0.00025	CcSEcCtD
Linezolid—Decreased appetite—Docetaxel—breast cancer	0.000187	0.00025	CcSEcCtD
Linezolid—Headache—Fluorouracil—breast cancer	0.000187	0.00025	CcSEcCtD
Linezolid—Dysgeusia—Methotrexate—breast cancer	0.000186	0.000249	CcSEcCtD
Linezolid—Gastrointestinal disorder—Docetaxel—breast cancer	0.000186	0.000248	CcSEcCtD
Linezolid—Dyspnoea—Capecitabine—breast cancer	0.000186	0.000248	CcSEcCtD
Linezolid—Fatigue—Docetaxel—breast cancer	0.000185	0.000248	CcSEcCtD
Linezolid—Nausea—Irinotecan—breast cancer	0.000185	0.000247	CcSEcCtD
Linezolid—Nausea—Mitoxantrone—breast cancer	0.000185	0.000247	CcSEcCtD
Linezolid—Constipation—Docetaxel—breast cancer	0.000184	0.000246	CcSEcCtD
Linezolid—Pain—Docetaxel—breast cancer	0.000184	0.000246	CcSEcCtD
Linezolid—Dyspepsia—Capecitabine—breast cancer	0.000183	0.000245	CcSEcCtD
Linezolid—Chills—Epirubicin—breast cancer	0.000183	0.000245	CcSEcCtD
Linezolid—MAOB—Metabolism—GPX2—breast cancer	0.000183	0.000969	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA2—breast cancer	0.000183	0.000969	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CDA—breast cancer	0.000183	0.000969	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SHMT1—breast cancer	0.000183	0.000969	CbGpPWpGaD
Linezolid—Asthenia—Paclitaxel—breast cancer	0.000182	0.000243	CcSEcCtD
Linezolid—Decreased appetite—Capecitabine—breast cancer	0.000181	0.000242	CcSEcCtD
Linezolid—MAOB—Metabolism—SULT1A1—breast cancer	0.000181	0.000958	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GPX4—breast cancer	0.000181	0.000958	CbGpPWpGaD
Linezolid—Nausea—Gemcitabine—breast cancer	0.00018	0.000241	CcSEcCtD
Linezolid—Gastrointestinal disorder—Capecitabine—breast cancer	0.00018	0.00024	CcSEcCtD
Linezolid—Fatigue—Capecitabine—breast cancer	0.000179	0.00024	CcSEcCtD
Linezolid—Pruritus—Paclitaxel—breast cancer	0.000179	0.00024	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000179	0.00095	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000179	0.000948	CbGpPWpGaD
Linezolid—Vision blurred—Methotrexate—breast cancer	0.000179	0.000239	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—breast cancer	0.000179	0.000239	CcSEcCtD
Linezolid—Pain—Capecitabine—breast cancer	0.000178	0.000238	CcSEcCtD
Linezolid—Constipation—Capecitabine—breast cancer	0.000178	0.000238	CcSEcCtD
Linezolid—Erythema—Epirubicin—breast cancer	0.000178	0.000238	CcSEcCtD
Linezolid—Nausea—Fluorouracil—breast cancer	0.000177	0.000237	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTA1—breast cancer	0.000177	0.000935	CbGpPWpGaD
Linezolid—MAOB—Metabolism—IDH1—breast cancer	0.000177	0.000935	CbGpPWpGaD
Linezolid—Tinnitus—Doxorubicin—breast cancer	0.000176	0.000236	CcSEcCtD
Linezolid—MAOA—Metabolism—SLCO1B1—breast cancer	0.000176	0.000932	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC2A5—breast cancer	0.000176	0.000932	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Docetaxel—breast cancer	0.000176	0.000235	CcSEcCtD
Linezolid—Anaemia—Methotrexate—breast cancer	0.000175	0.000235	CcSEcCtD
Linezolid—Flatulence—Epirubicin—breast cancer	0.000175	0.000234	CcSEcCtD
Linezolid—MAOB—Metabolism—NAT2—breast cancer	0.000175	0.000925	CbGpPWpGaD
Linezolid—Dysgeusia—Epirubicin—breast cancer	0.000174	0.000233	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—JUN—breast cancer	0.000174	0.000921	CbGpPWpGaD
Linezolid—Diarrhoea—Paclitaxel—breast cancer	0.000174	0.000232	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000173	0.000914	CbGpPWpGaD
Linezolid—Muscle spasms—Epirubicin—breast cancer	0.000171	0.000229	CcSEcCtD
Linezolid—Vertigo—Methotrexate—breast cancer	0.000171	0.000228	CcSEcCtD
Linezolid—Gastrointestinal pain—Capecitabine—breast cancer	0.00017	0.000228	CcSEcCtD
Linezolid—MAOA—Metabolism—APRT—breast cancer	0.00017	0.000901	CbGpPWpGaD
Linezolid—Abdominal pain—Docetaxel—breast cancer	0.00017	0.000227	CcSEcCtD
Linezolid—Body temperature increased—Docetaxel—breast cancer	0.00017	0.000227	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—breast cancer	0.00017	0.000227	CcSEcCtD
Linezolid—Chills—Doxorubicin—breast cancer	0.000169	0.000227	CcSEcCtD
Linezolid—Dizziness—Paclitaxel—breast cancer	0.000168	0.000224	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—breast cancer	0.000167	0.000224	CcSEcCtD
Linezolid—Cough—Methotrexate—breast cancer	0.000166	0.000222	CcSEcCtD
Linezolid—Urticaria—Capecitabine—breast cancer	0.000165	0.000221	CcSEcCtD
Linezolid—Abdominal pain—Capecitabine—breast cancer	0.000165	0.00022	CcSEcCtD
Linezolid—Body temperature increased—Capecitabine—breast cancer	0.000165	0.00022	CcSEcCtD
Linezolid—Convulsion—Methotrexate—breast cancer	0.000164	0.00022	CcSEcCtD
Linezolid—Erythema—Doxorubicin—breast cancer	0.000164	0.00022	CcSEcCtD
Linezolid—Anaemia—Epirubicin—breast cancer	0.000164	0.00022	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—MDM2—breast cancer	0.000164	0.000869	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—RAF1—breast cancer	0.000163	0.000866	CbGpPWpGaD
Linezolid—Flatulence—Doxorubicin—breast cancer	0.000162	0.000217	CcSEcCtD
Linezolid—Vomiting—Paclitaxel—breast cancer	0.000161	0.000216	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—breast cancer	0.000161	0.000215	CcSEcCtD
Linezolid—Rash—Paclitaxel—breast cancer	0.00016	0.000214	CcSEcCtD
Linezolid—MAOA—Metabolism—ESRRA—breast cancer	0.00016	0.000847	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ANGPTL4—breast cancer	0.00016	0.000847	CbGpPWpGaD
Linezolid—Dermatitis—Paclitaxel—breast cancer	0.00016	0.000214	CcSEcCtD
Linezolid—Vertigo—Epirubicin—breast cancer	0.00016	0.000214	CcSEcCtD
Linezolid—Leukopenia—Epirubicin—breast cancer	0.000159	0.000213	CcSEcCtD
Linezolid—Headache—Paclitaxel—breast cancer	0.000159	0.000213	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—breast cancer	0.000158	0.000211	CcSEcCtD
Linezolid—Cough—Epirubicin—breast cancer	0.000155	0.000207	CcSEcCtD
Linezolid—Anaphylactic shock—Methotrexate—breast cancer	0.000155	0.000207	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—breast cancer	0.000155	0.000207	CcSEcCtD
Linezolid—Asthenia—Docetaxel—breast cancer	0.000154	0.000206	CcSEcCtD
Linezolid—Convulsion—Epirubicin—breast cancer	0.000154	0.000206	CcSEcCtD
Linezolid—Hypertension—Epirubicin—breast cancer	0.000153	0.000205	CcSEcCtD
Linezolid—MAOB—Metabolism—DPYD—breast cancer	0.000153	0.000811	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MED12—breast cancer	0.000153	0.000811	CbGpPWpGaD
Linezolid—Pruritus—Docetaxel—breast cancer	0.000152	0.000204	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—breast cancer	0.000152	0.000203	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.000152	0.000805	CbGpPWpGaD
Linezolid—Thrombocytopenia—Methotrexate—breast cancer	0.000152	0.000203	CcSEcCtD
Linezolid—MAOA—Metabolism—HADHB—breast cancer	0.000152	0.000803	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPI—breast cancer	0.000152	0.000803	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALDOA—breast cancer	0.000151	0.000798	CbGpPWpGaD
Linezolid—Nausea—Paclitaxel—breast cancer	0.000151	0.000202	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—breast cancer	0.00015	0.000201	CcSEcCtD
Linezolid—MAOA—Neuronal System—BRAF—breast cancer	0.00015	0.000794	CbGpPWpGaD
Linezolid—Hyperhidrosis—Methotrexate—breast cancer	0.00015	0.0002	CcSEcCtD
Linezolid—Asthenia—Capecitabine—breast cancer	0.000149	0.0002	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—breast cancer	0.000148	0.000198	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—breast cancer	0.000148	0.000198	CcSEcCtD
Linezolid—Anorexia—Methotrexate—breast cancer	0.000148	0.000198	CcSEcCtD
Linezolid—Pruritus—Capecitabine—breast cancer	0.000147	0.000197	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—breast cancer	0.000147	0.000197	CcSEcCtD
Linezolid—Diarrhoea—Docetaxel—breast cancer	0.000147	0.000197	CcSEcCtD
Linezolid—MAOB—Metabolism—NCOA3—breast cancer	0.000146	0.000775	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC2A2—breast cancer	0.000145	0.00077	CbGpPWpGaD
Linezolid—Anaphylactic shock—Epirubicin—breast cancer	0.000145	0.000194	CcSEcCtD
Linezolid—MAOA—Metabolism—ALDH1A1—breast cancer	0.000145	0.000766	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALDH7A1—breast cancer	0.000145	0.000766	CbGpPWpGaD
Linezolid—Cough—Doxorubicin—breast cancer	0.000143	0.000192	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—breast cancer	0.000142	0.000191	CcSEcCtD
Linezolid—Diarrhoea—Capecitabine—breast cancer	0.000142	0.000191	CcSEcCtD
Linezolid—MAOB—Metabolism—MTR—breast cancer	0.000142	0.000754	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCG2—breast cancer	0.000142	0.000754	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CPT1A—breast cancer	0.000142	0.000754	CbGpPWpGaD
Linezolid—Dizziness—Docetaxel—breast cancer	0.000142	0.00019	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—breast cancer	0.000142	0.00019	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—breast cancer	0.000142	0.00019	CcSEcCtD
Linezolid—Skin disorder—Epirubicin—breast cancer	0.000141	0.000188	CcSEcCtD
Linezolid—Hyperhidrosis—Epirubicin—breast cancer	0.00014	0.000188	CcSEcCtD
Linezolid—Insomnia—Methotrexate—breast cancer	0.00014	0.000188	CcSEcCtD
Linezolid—MAOB—Metabolism—HPGDS—breast cancer	0.00014	0.000739	CbGpPWpGaD
Linezolid—Paraesthesia—Methotrexate—breast cancer	0.000139	0.000186	CcSEcCtD
Linezolid—MAOB—Metabolism—HBA1—breast cancer	0.000139	0.000735	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UMPS—breast cancer	0.000139	0.000734	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADSL—breast cancer	0.000139	0.000734	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NME1—breast cancer	0.000139	0.000734	CbGpPWpGaD
Linezolid—MAOA—Metabolism—FHL2—breast cancer	0.000139	0.000734	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PHGDH—breast cancer	0.000139	0.000734	CbGpPWpGaD
Linezolid—Anorexia—Epirubicin—breast cancer	0.000138	0.000185	CcSEcCtD
Linezolid—Dyspnoea—Methotrexate—breast cancer	0.000138	0.000185	CcSEcCtD
Linezolid—Somnolence—Methotrexate—breast cancer	0.000138	0.000184	CcSEcCtD
Linezolid—Dizziness—Capecitabine—breast cancer	0.000138	0.000184	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—breast cancer	0.000137	0.000183	CcSEcCtD
Linezolid—Vomiting—Docetaxel—breast cancer	0.000137	0.000183	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—breast cancer	0.000136	0.000183	CcSEcCtD
Linezolid—MAOA—Metabolism—HPSE—breast cancer	0.000136	0.00072	CbGpPWpGaD
Linezolid—MAOA—Metabolism—BRIP1—breast cancer	0.000136	0.00072	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LDHB—breast cancer	0.000136	0.00072	CbGpPWpGaD
Linezolid—Rash—Docetaxel—breast cancer	0.000136	0.000181	CcSEcCtD
Linezolid—Dermatitis—Docetaxel—breast cancer	0.000135	0.000181	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTT1—breast cancer	0.000135	0.000717	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ACHE—breast cancer	0.000135	0.000717	CbGpPWpGaD
Linezolid—Decreased appetite—Methotrexate—breast cancer	0.000135	0.00018	CcSEcCtD
Linezolid—Headache—Docetaxel—breast cancer	0.000135	0.00018	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—breast cancer	0.000134	0.00018	CcSEcCtD
Linezolid—Gastrointestinal disorder—Methotrexate—breast cancer	0.000134	0.000179	CcSEcCtD
Linezolid—Fatigue—Methotrexate—breast cancer	0.000134	0.000179	CcSEcCtD
Linezolid—Pain—Methotrexate—breast cancer	0.000132	0.000177	CcSEcCtD
Linezolid—Vomiting—Capecitabine—breast cancer	0.000132	0.000177	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—breast cancer	0.000131	0.000176	CcSEcCtD
Linezolid—Rash—Capecitabine—breast cancer	0.000131	0.000176	CcSEcCtD
Linezolid—Insomnia—Epirubicin—breast cancer	0.000131	0.000175	CcSEcCtD
Linezolid—Dermatitis—Capecitabine—breast cancer	0.000131	0.000175	CcSEcCtD
Linezolid—Headache—Capecitabine—breast cancer	0.00013	0.000174	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—breast cancer	0.00013	0.000174	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—breast cancer	0.00013	0.000174	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—TNF—breast cancer	0.00013	0.00069	CbGpPWpGaD
Linezolid—Hyperhidrosis—Doxorubicin—breast cancer	0.00013	0.000174	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—breast cancer	0.000129	0.000173	CcSEcCtD
Linezolid—Somnolence—Epirubicin—breast cancer	0.000129	0.000172	CcSEcCtD
Linezolid—MAOA—Metabolism—HMMR—breast cancer	0.000129	0.000682	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA3—breast cancer	0.000129	0.000682	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCC1—breast cancer	0.000129	0.000682	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP17A1—breast cancer	0.000128	0.000679	CbGpPWpGaD
Linezolid—Anorexia—Doxorubicin—breast cancer	0.000128	0.000171	CcSEcCtD
Linezolid—Nausea—Docetaxel—breast cancer	0.000128	0.000171	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—breast cancer	0.000128	0.000171	CcSEcCtD
Linezolid—MAOB—Metabolism—ENO1—breast cancer	0.000127	0.000672	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS1—breast cancer	0.000127	0.000672	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Methotrexate—breast cancer	0.000127	0.00017	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—breast cancer	0.000126	0.000169	CcSEcCtD
Linezolid—MAOA—Neuronal System—MDM2—breast cancer	0.000126	0.000666	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—RAF1—breast cancer	0.000125	0.000663	CbGpPWpGaD
Linezolid—Gastrointestinal disorder—Epirubicin—breast cancer	0.000125	0.000168	CcSEcCtD
Linezolid—Fatigue—Epirubicin—breast cancer	0.000125	0.000167	CcSEcCtD
Linezolid—MAOA—Metabolism—PPARGC1B—breast cancer	0.000125	0.000661	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2D6—breast cancer	0.000124	0.000659	CbGpPWpGaD
Linezolid—Constipation—Epirubicin—breast cancer	0.000124	0.000166	CcSEcCtD
Linezolid—Pain—Epirubicin—breast cancer	0.000124	0.000166	CcSEcCtD
Linezolid—Nausea—Capecitabine—breast cancer	0.000124	0.000165	CcSEcCtD
Linezolid—Urticaria—Methotrexate—breast cancer	0.000123	0.000165	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—breast cancer	0.000122	0.000164	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—breast cancer	0.000122	0.000164	CcSEcCtD
Linezolid—MAOB—Metabolism—NCOA2—breast cancer	0.000122	0.000647	CbGpPWpGaD
Linezolid—Insomnia—Doxorubicin—breast cancer	0.000121	0.000162	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—breast cancer	0.00012	0.000161	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—breast cancer	0.00012	0.00016	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—breast cancer	0.000119	0.00016	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—breast cancer	0.000119	0.000159	CcSEcCtD
Linezolid—MAOB—Metabolism—FASN—breast cancer	0.000118	0.000627	CbGpPWpGaD
Linezolid—Dyspepsia—Doxorubicin—breast cancer	0.000118	0.000158	CcSEcCtD
Linezolid—MAOB—Metabolism—BCHE—breast cancer	0.000118	0.000625	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CA9—breast cancer	0.000118	0.000624	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA4—breast cancer	0.000118	0.000624	CbGpPWpGaD
Linezolid—Decreased appetite—Doxorubicin—breast cancer	0.000117	0.000156	CcSEcCtD
Linezolid—MAOB—Metabolism—SLC5A5—breast cancer	0.000116	0.000617	CbGpPWpGaD
Linezolid—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000116	0.000155	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—breast cancer	0.000116	0.000155	CcSEcCtD
Linezolid—Urticaria—Epirubicin—breast cancer	0.000115	0.000154	CcSEcCtD
Linezolid—MAOA—Metabolism—GPX2—breast cancer	0.000115	0.000608	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA2—breast cancer	0.000115	0.000608	CbGpPWpGaD
Linezolid—Pain—Doxorubicin—breast cancer	0.000115	0.000154	CcSEcCtD
Linezolid—Constipation—Doxorubicin—breast cancer	0.000115	0.000154	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—breast cancer	0.000115	0.000153	CcSEcCtD
Linezolid—Body temperature increased—Epirubicin—breast cancer	0.000115	0.000153	CcSEcCtD
Linezolid—MAOA—Metabolism—SULT1A1—breast cancer	0.000113	0.000601	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPX4—breast cancer	0.000113	0.000601	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NQO1—breast cancer	0.000113	0.000596	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC2A1—breast cancer	0.000113	0.000596	CbGpPWpGaD
Linezolid—Asthenia—Methotrexate—breast cancer	0.000111	0.000149	CcSEcCtD
Linezolid—MAOA—Metabolism—IDH1—breast cancer	0.000111	0.000587	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA1—breast cancer	0.000111	0.000587	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP3A4—breast cancer	0.00011	0.000581	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Doxorubicin—breast cancer	0.00011	0.000147	CcSEcCtD
Linezolid—Pruritus—Methotrexate—breast cancer	0.00011	0.000147	CcSEcCtD
Linezolid—MAOA—Metabolism—NAT2—breast cancer	0.00011	0.00058	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP1B1—breast cancer	0.000108	0.000571	CbGpPWpGaD
Linezolid—Urticaria—Doxorubicin—breast cancer	0.000107	0.000143	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—breast cancer	0.000106	0.000142	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—breast cancer	0.000106	0.000142	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—breast cancer	0.000106	0.000142	CcSEcCtD
Linezolid—MAOB—Metabolism—HSP90AA1—breast cancer	0.000106	0.00056	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—breast cancer	0.000105	0.000557	CbGpPWpGaD
Linezolid—Asthenia—Epirubicin—breast cancer	0.000104	0.000139	CcSEcCtD
Linezolid—MAOB—Metabolism—NCOA1—breast cancer	0.000103	0.000545	CbGpPWpGaD
Linezolid—Pruritus—Epirubicin—breast cancer	0.000103	0.000137	CcSEcCtD
Linezolid—Dizziness—Methotrexate—breast cancer	0.000102	0.000137	CcSEcCtD
Linezolid—MAOB—Metabolism—STK11—breast cancer	0.000101	0.000537	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP19A1—breast cancer	0.000101	0.000537	CbGpPWpGaD
Linezolid—Diarrhoea—Epirubicin—breast cancer	9.92e-05	0.000133	CcSEcCtD
Linezolid—Vomiting—Methotrexate—breast cancer	9.85e-05	0.000132	CcSEcCtD
Linezolid—Rash—Methotrexate—breast cancer	9.77e-05	0.000131	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—breast cancer	9.76e-05	0.000131	CcSEcCtD
Linezolid—Headache—Methotrexate—breast cancer	9.71e-05	0.00013	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—breast cancer	9.63e-05	0.000129	CcSEcCtD
Linezolid—MAOA—Metabolism—DPYD—breast cancer	9.61e-05	0.000509	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MED12—breast cancer	9.61e-05	0.000509	CbGpPWpGaD
Linezolid—Dizziness—Epirubicin—breast cancer	9.59e-05	0.000128	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—breast cancer	9.49e-05	0.000127	CcSEcCtD
Linezolid—MAOA—Metabolism—ALDOA—breast cancer	9.46e-05	0.000501	CbGpPWpGaD
Linezolid—MAOB—Metabolism—COMT—breast cancer	9.43e-05	0.000499	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTP1—breast cancer	9.38e-05	0.000497	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMOX1—breast cancer	9.25e-05	0.00049	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ITPR1—breast cancer	9.23e-05	0.000489	CbGpPWpGaD
Linezolid—Vomiting—Epirubicin—breast cancer	9.22e-05	0.000123	CcSEcCtD
Linezolid—Nausea—Methotrexate—breast cancer	9.2e-05	0.000123	CcSEcCtD
Linezolid—MAOA—Metabolism—NCOA3—breast cancer	9.18e-05	0.000486	CbGpPWpGaD
Linezolid—Diarrhoea—Doxorubicin—breast cancer	9.18e-05	0.000123	CcSEcCtD
Linezolid—Rash—Epirubicin—breast cancer	9.14e-05	0.000122	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—breast cancer	9.13e-05	0.000122	CcSEcCtD
Linezolid—MAOA—Metabolism—SLC2A2—breast cancer	9.12e-05	0.000483	CbGpPWpGaD
Linezolid—Headache—Epirubicin—breast cancer	9.08e-05	0.000122	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—HRAS—breast cancer	9e-05	0.000477	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTR—breast cancer	8.93e-05	0.000473	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CPT1A—breast cancer	8.93e-05	0.000473	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCG2—breast cancer	8.93e-05	0.000473	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCB1—breast cancer	8.88e-05	0.00047	CbGpPWpGaD
Linezolid—Dizziness—Doxorubicin—breast cancer	8.87e-05	0.000119	CcSEcCtD
Linezolid—MAOA—Metabolism—HPGDS—breast cancer	8.76e-05	0.000464	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TYMS—breast cancer	8.72e-05	0.000462	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HBA1—breast cancer	8.7e-05	0.000461	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLA2G4A—breast cancer	8.62e-05	0.000457	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM1—breast cancer	8.62e-05	0.000457	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NCOR1—breast cancer	8.62e-05	0.000457	CbGpPWpGaD
Linezolid—Nausea—Epirubicin—breast cancer	8.61e-05	0.000115	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—breast cancer	8.53e-05	0.000114	CcSEcCtD
Linezolid—MAOA—Metabolism—ACHE—breast cancer	8.49e-05	0.00045	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTT1—breast cancer	8.49e-05	0.00045	CbGpPWpGaD
Linezolid—Rash—Doxorubicin—breast cancer	8.46e-05	0.000113	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—breast cancer	8.45e-05	0.000113	CcSEcCtD
Linezolid—Headache—Doxorubicin—breast cancer	8.4e-05	0.000112	CcSEcCtD
Linezolid—MAOB—Metabolism—GPX1—breast cancer	8.26e-05	0.000437	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP1A1—breast cancer	8.17e-05	0.000433	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ERCC2—breast cancer	8.11e-05	0.000429	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP17A1—breast cancer	8.04e-05	0.000426	CbGpPWpGaD
Linezolid—Nausea—Doxorubicin—breast cancer	7.97e-05	0.000107	CcSEcCtD
Linezolid—MAOA—Metabolism—ENO1—breast cancer	7.96e-05	0.000422	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS1—breast cancer	7.96e-05	0.000422	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2D6—breast cancer	7.81e-05	0.000413	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA2—breast cancer	7.66e-05	0.000406	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTHFR—breast cancer	7.62e-05	0.000404	CbGpPWpGaD
Linezolid—MAOA—Metabolism—FASN—breast cancer	7.43e-05	0.000394	CbGpPWpGaD
Linezolid—MAOA—Metabolism—BCHE—breast cancer	7.4e-05	0.000392	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC5A5—breast cancer	7.31e-05	0.000387	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NQO1—breast cancer	7.06e-05	0.000374	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC2A1—breast cancer	7.06e-05	0.000374	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CAV1—breast cancer	7.03e-05	0.000372	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—HRAS—breast cancer	6.89e-05	0.000365	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP3A4—breast cancer	6.88e-05	0.000365	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP1B1—breast cancer	6.77e-05	0.000359	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSP90AA1—breast cancer	6.64e-05	0.000352	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA1—breast cancer	6.46e-05	0.000342	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CG—breast cancer	6.4e-05	0.000339	CbGpPWpGaD
Linezolid—MAOA—Metabolism—STK11—breast cancer	6.36e-05	0.000337	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP19A1—breast cancer	6.36e-05	0.000337	CbGpPWpGaD
Linezolid—MAOA—Metabolism—COMT—breast cancer	5.92e-05	0.000313	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTP1—breast cancer	5.89e-05	0.000312	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMOX1—breast cancer	5.81e-05	0.000308	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ITPR1—breast cancer	5.79e-05	0.000307	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CD—breast cancer	5.63e-05	0.000298	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCB1—breast cancer	5.57e-05	0.000295	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALB—breast cancer	5.56e-05	0.000294	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TYMS—breast cancer	5.47e-05	0.00029	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM1—breast cancer	5.41e-05	0.000287	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLA2G4A—breast cancer	5.41e-05	0.000287	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOR1—breast cancer	5.41e-05	0.000287	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NOS3—breast cancer	5.31e-05	0.000282	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPX1—breast cancer	5.18e-05	0.000274	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP1A1—breast cancer	5.13e-05	0.000272	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ERCC2—breast cancer	5.09e-05	0.000269	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CB—breast cancer	4.91e-05	0.00026	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—breast cancer	4.86e-05	0.000257	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTHFR—breast cancer	4.78e-05	0.000253	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CAV1—breast cancer	4.41e-05	0.000234	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTEN—breast cancer	4.24e-05	0.000225	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CG—breast cancer	4.02e-05	0.000213	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CD—breast cancer	3.53e-05	0.000187	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALB—breast cancer	3.49e-05	0.000185	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NOS3—breast cancer	3.33e-05	0.000177	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CB—breast cancer	3.08e-05	0.000163	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—breast cancer	3.05e-05	0.000162	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CA—breast cancer	2.99e-05	0.000158	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTEN—breast cancer	2.66e-05	0.000141	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AKT1—breast cancer	2.44e-05	0.000129	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CA—breast cancer	1.88e-05	9.94e-05	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKT1—breast cancer	1.53e-05	8.12e-05	CbGpPWpGaD
